[Xylocaine--anti-arrhythmic activity, clinical tolerance and hemodynamic repercussions (comparison with ajamline)].
D000404:Ajmaline / Q000494:pharmacology / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004361:Drug Tolerance; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000627:therapeutic use*
D000404:Ajmaline; D008012:Lidocaine
La xylocaïne--action antiarhthmique, tolérance clinique et répercussions hémodynamiques (comparaison aec l'ajmaline.